Inherent Biosciences Raises Seed Round, Adds Board Members and Clinical Advisors
Inherent Biosciences Raises Seed Round, Adds Board Members and Clinical Advisors Funding will be used to clinically validate and launch the company's proprietary male infertility diagnostic News provided by Share this article Share this article SALT LAKE CITY, Feb. 17, 2021 /PRNewswire/ -- Inherent Biosciences today announced its initial capital raise led by Morning Star Foundation with additional participation from MedMountain Ventures, Kickstart Funds, Park City Angels, Rhythm VC and several angel investors. With the initial funding, Inherent will launch a male infertility diagnostic to gu...
Source: prnewswire.com